The FDA approved leucovorin for cerebral folate deficiency linked to FOLR1 mutations but said evidence is insufficient to support approval for autism.
Leucovorin is being reviewed by the FDA for treating cerebral folate deficiency, which causes developmental delays and autism-like features in children. GSK aims to update leucovorin's label for CFD ...
A study in the journal Pharmaceuticals has uncovered how specific genetic mutations in α 2 δ-1 and α 2 δ-3 proteins linked to ...
Please provide your email address to receive an email when new articles are posted on . The FDA said its literature review found that leucovorin calcium can treat cerebral folate deficiency. Experts ...
Please provide your email address to receive an email when new articles are posted on . ASD Insight can be performed by qualified health care professionals. Results from the test are available as soon ...
ASD Insight Test is a Critical Step in Redefining Autism as a Biologically Measurable Condition NeuroQure, a pioneering leader in neurological diagnostics, announces the launch of ASD Insight, a first ...